Skip to main content
Erschienen in: Journal of Urban Health 1/2018

16.08.2017

Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico

verfasst von: Amen Ben Hamida, Claudia Rafful, Sonia Jain, Shelly Sun, Patricia Gonzalez-Zuniga, Gudelia Rangel, Steffanie A. Strathdee, Dan Werb

Erschienen in: Journal of Urban Health | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Although most people who inject drugs (PWID) report receiving assistance during injection initiation events, little research has focused on risk factors among PWID for providing injection initiation assistance. We therefore sought to determine the influence of non-injection drug use among PWID on their risk to initiate others. We used generalized estimating equation (GEE) models on longitudinal data among a prospective cohort of PWID in Tijuana, Mexico (Proyecto El Cuete IV), while controlling for potential confounders. At baseline, 534 participants provided data on injection initiation assistance. Overall, 14% reported ever initiating others, with 4% reporting this behavior recently (i.e., in the past 6 months). In a multivariable GEE model, recent non-injection drug use was independently associated with providing injection initiation assistance (adjusted odds ratio [AOR] = 2.42, 95% confidence interval [CI] = 1.39–4.20). Further, in subanalyses examining specific drug types, recent non-injection use of cocaine (AOR = 9.31, 95% CI = 3.98–21.78), heroin (AOR = 4.00, 95% CI = 1.88–8.54), and methamphetamine (AOR = 2.03, 95% CI = 1.16–3.55) were all significantly associated with reporting providing injection initiation assistance. Our findings may have important implications for the development of interventional approaches to reduce injection initiation and related harms. Further research is needed to validate findings and inform future approaches to preventing entry into drug injecting.
Literatur
3.
Zurück zum Zitat Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271–8.CrossRefPubMed Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271–8.CrossRefPubMed
4.
Zurück zum Zitat Mehta SH, McFall AM, Srikrishnan AK, et al. Morbidity and mortality among community-based people who inject drugs with a high hepatitis C and human immunodeficiency virus burden in Chennai, India. Open Forum Infect Dis . 2016;3(3):ofw121. Mehta SH, McFall AM, Srikrishnan AK, et al. Morbidity and mortality among community-based people who inject drugs with a high hepatitis C and human immunodeficiency virus burden in Chennai, India. Open Forum Infect Dis . 2016;3(3):ofw121.
5.
Zurück zum Zitat Lumbreras B, Jarrin I, del Amo J, et al. Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART. AIDS. 2006;20(1):111–6. Lumbreras B, Jarrin I, del Amo J, et al. Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART. AIDS. 2006;20(1):111–6.
6.
Zurück zum Zitat Rockstroh JK. Influence of viral hepatitis on HIV infection. J Hepatol. 2006;44(1 Suppl):S25–7. Rockstroh JK. Influence of viral hepatitis on HIV infection. J Hepatol. 2006;44(1 Suppl):S25–7.
7.
Zurück zum Zitat Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health. 2008;8:405.CrossRefPubMedPubMedCentral Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health. 2008;8:405.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Millar B, Moore J. Emerging issues in infective endocarditis. Emerg Infect Dis J 2004;Volume 10. Millar B, Moore J. Emerging issues in infective endocarditis. Emerg Infect Dis J 2004;Volume 10.
9.
Zurück zum Zitat Milloy MJ, Kerr T, Tyndall M, Montaner J, Wood E. Estimated drug overdose deaths averted by North America’s first medically-supervised safer injection facility. PLoS One. 2008;3(10):e3351.CrossRefPubMedPubMedCentral Milloy MJ, Kerr T, Tyndall M, Montaner J, Wood E. Estimated drug overdose deaths averted by North America’s first medically-supervised safer injection facility. PLoS One. 2008;3(10):e3351.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14–9. Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14–9.
11.
Zurück zum Zitat Werb D, Garfein R, Kerr T, et al. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016;13(1):25.CrossRefPubMedPubMedCentral Werb D, Garfein R, Kerr T, et al. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016;13(1):25.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Bluthenthal RN, Kral AH. Next steps in research on injection initiation incidence and prevention. Addiction. 2015;110(8):1258–9.CrossRefPubMed Bluthenthal RN, Kral AH. Next steps in research on injection initiation incidence and prevention. Addiction. 2015;110(8):1258–9.CrossRefPubMed
13.
Zurück zum Zitat Debeck K, Kerr T, Marshall BD, Simo A, Montaner J, Wood E. Risk factors for progression to regular injection drug use among street-involved youth in a Canadian setting. Drug Alcohol Depend. 2013;133(2):468–72.CrossRefPubMed Debeck K, Kerr T, Marshall BD, Simo A, Montaner J, Wood E. Risk factors for progression to regular injection drug use among street-involved youth in a Canadian setting. Drug Alcohol Depend. 2013;133(2):468–72.CrossRefPubMed
14.
Zurück zum Zitat van Ameijden EJ, van den Hoek JA, Hartgers C, Coutinho RA. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol. 1994;139(12):1153–63.CrossRefPubMed van Ameijden EJ, van den Hoek JA, Hartgers C, Coutinho RA. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol. 1994;139(12):1153–63.CrossRefPubMed
15.
Zurück zum Zitat Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996;86(5):655–61.CrossRefPubMedPubMedCentral Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996;86(5):655–61.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Carneiro M, Fuller C, Doherty MC, Vlahov D. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug Alcohol Depend. 1999;54(1):83–6.CrossRefPubMed Carneiro M, Fuller C, Doherty MC, Vlahov D. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug Alcohol Depend. 1999;54(1):83–6.CrossRefPubMed
17.
Zurück zum Zitat Kral AH, Lorvick J, Edlin BR. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr. 2000;24(2):162–7.CrossRefPubMed Kral AH, Lorvick J, Edlin BR. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr. 2000;24(2):162–7.CrossRefPubMed
18.
Zurück zum Zitat Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000;14(6):717–26.CrossRefPubMed Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000;14(6):717–26.CrossRefPubMed
19.
Zurück zum Zitat Strike C, Rotondi M, Kolla G, et al. Interrupting the social processes linked with initiation of injection drug use: results from a pilot study. Drug Alcohol Depend. 2014;137:48–54.CrossRefPubMed Strike C, Rotondi M, Kolla G, et al. Interrupting the social processes linked with initiation of injection drug use: results from a pilot study. Drug Alcohol Depend. 2014;137:48–54.CrossRefPubMed
20.
Zurück zum Zitat Brouwer KC, Case P, Ramos R, et al. Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Subst Use Misuse. 2006;41(5):707–27.CrossRefPubMedPubMedCentral Brouwer KC, Case P, Ramos R, et al. Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Subst Use Misuse. 2006;41(5):707–27.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Magis-Rodriguez C, Brouwer KC, Morales S, et al. HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana. J Psychoactive Drugs. 2005;37(3):333–9.CrossRefPubMed Magis-Rodriguez C, Brouwer KC, Morales S, et al. HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana. J Psychoactive Drugs. 2005;37(3):333–9.CrossRefPubMed
22.
Zurück zum Zitat Strathdee SA, Lozada R, Pollini RA, et al. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana. Mexico J Acquir Immune Defic Syndr. 2008;47(3):369–76. Strathdee SA, Lozada R, Pollini RA, et al. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana. Mexico J Acquir Immune Defic Syndr. 2008;47(3):369–76.
24.
Zurück zum Zitat Werb D, Buxton J, Shoveller J, Richardson C, Rowell G, Wood E. Interventions to prevent the initiation of injection drug use: a systematic review. Drug Alcohol Depend. 2013;133(2):669–76.CrossRefPubMed Werb D, Buxton J, Shoveller J, Richardson C, Rowell G, Wood E. Interventions to prevent the initiation of injection drug use: a systematic review. Drug Alcohol Depend. 2013;133(2):669–76.CrossRefPubMed
25.
Zurück zum Zitat Bryant J, Treloar C. The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug Alcohol Rev. 2007;26(3):287–93.CrossRefPubMed Bryant J, Treloar C. The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug Alcohol Rev. 2007;26(3):287–93.CrossRefPubMed
26.
Zurück zum Zitat Crofts N, Louie R, Rosenthal D, Jolley D. The first hit: circumstances surrounding initiation into injecting. Addiction. 1996;91(8):1187–96.CrossRefPubMed Crofts N, Louie R, Rosenthal D, Jolley D. The first hit: circumstances surrounding initiation into injecting. Addiction. 1996;91(8):1187–96.CrossRefPubMed
27.
Zurück zum Zitat Doherty MC, Garfein RS, Monterroso E, Latkin C, Vlahov D. Gender differences in the initiation of injection drug use among young adults. J Urban Health. 2000;77(3):396–414. Doherty MC, Garfein RS, Monterroso E, Latkin C, Vlahov D. Gender differences in the initiation of injection drug use among young adults. J Urban Health. 2000;77(3):396–414.
28.
Zurück zum Zitat Goldsamt LA, Harocopos A, Kobrak P, Jost JJ, Clatts MC. Circumstances, pedagogy and rationales for injection initiation among new drug injectors. J Community Health. 2010;35(3):258–67. Goldsamt LA, Harocopos A, Kobrak P, Jost JJ, Clatts MC. Circumstances, pedagogy and rationales for injection initiation among new drug injectors. J Community Health. 2010;35(3):258–67.
29.
Zurück zum Zitat Harocopos A, Goldsamt LA, Kobrak P, Jost JJ, Clatts MC. New injectors and the social context of injection initiation. Int J Drug Policy. 2009;20(4):317–23. Harocopos A, Goldsamt LA, Kobrak P, Jost JJ, Clatts MC. New injectors and the social context of injection initiation. Int J Drug Policy. 2009;20(4):317–23.
30.
Zurück zum Zitat Rahimi-Movaghar A, Amin-Esmaeili M, Shadloo B, Noroozi A, Malekinejad M. Transition to injecting drug use in Iran: a systematic review of qualitative and quantitative evidence. Int J Drug Pol. 2015;26(9):808–19. Rahimi-Movaghar A, Amin-Esmaeili M, Shadloo B, Noroozi A, Malekinejad M. Transition to injecting drug use in Iran: a systematic review of qualitative and quantitative evidence. Int J Drug Pol. 2015;26(9):808–19.
31.
Zurück zum Zitat Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin JF. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003;80(1):92–105. Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin JF. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003;80(1):92–105.
32.
Zurück zum Zitat Rotondi NK, Strike C, Kolla G, et al. Transition to injection drug use: the role of initiators. AIDS Behav. 2014;18(3):486–94.CrossRefPubMed Rotondi NK, Strike C, Kolla G, et al. Transition to injection drug use: the role of initiators. AIDS Behav. 2014;18(3):486–94.CrossRefPubMed
33.
Zurück zum Zitat Kermode M, Longleng V, Singh BC, Hocking J, Langkham B, Crofts N. My first time: initiation into injecting drug use in Manipur and Nagaland, north-east India. Harm Reduct J. 2007;4:19.CrossRefPubMedPubMedCentral Kermode M, Longleng V, Singh BC, Hocking J, Langkham B, Crofts N. My first time: initiation into injecting drug use in Manipur and Nagaland, north-east India. Harm Reduct J. 2007;4:19.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Bluthenthal RN, Wenger L, Chu D, Quinn B, Thing J, Kral AH. Factors associated with initiating someone into illicit drug injection. Drug Alcohol Depend. 2014;144:186–92.CrossRefPubMedPubMedCentral Bluthenthal RN, Wenger L, Chu D, Quinn B, Thing J, Kral AH. Factors associated with initiating someone into illicit drug injection. Drug Alcohol Depend. 2014;144:186–92.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Bryant J, Treloar C. Initiators: an examination of young injecting drug users who initiate others to injecting. AIDS Behav. 2008;12(6):885–90.CrossRefPubMed Bryant J, Treloar C. Initiators: an examination of young injecting drug users who initiate others to injecting. AIDS Behav. 2008;12(6):885–90.CrossRefPubMed
36.
Zurück zum Zitat Werb D, Kerr T, Buxton J, et al. Crystal methamphetamine and initiation of injection drug use among street-involved youth in a Canadian setting. CMAJ. 2013;185(18):1569–75.CrossRefPubMedPubMedCentral Werb D, Kerr T, Buxton J, et al. Crystal methamphetamine and initiation of injection drug use among street-involved youth in a Canadian setting. CMAJ. 2013;185(18):1569–75.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Young AM, Havens JR. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction. 2012;107(3):587–96.CrossRefPubMed Young AM, Havens JR. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction. 2012;107(3):587–96.CrossRefPubMed
38.
Zurück zum Zitat DeBeck K, Wood E, Dong H, et al. Non-medical prescription opioid use predicts injection initiation among street-involved youth. Int J Drug Policy. 2016;34:96–100. DeBeck K, Wood E, Dong H, et al. Non-medical prescription opioid use predicts injection initiation among street-involved youth. Int J Drug Policy. 2016;34:96–100.
39.
Zurück zum Zitat Werb D, Garfein RS, Kerr T, et al. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016;13(1):25. Werb D, Garfein RS, Kerr T, et al. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016;13(1):25.
40.
Zurück zum Zitat Zeger SL, Liang K-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121–30.CrossRefPubMed Zeger SL, Liang K-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121–30.CrossRefPubMed
41.
Zurück zum Zitat Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366(9482):316–8.CrossRefPubMed Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366(9482):316–8.CrossRefPubMed
42.
Zurück zum Zitat Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ. 2006;175(11):1399–404.CrossRefPubMedPubMedCentral Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ. 2006;175(11):1399–404.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429–37.CrossRefPubMed Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429–37.CrossRefPubMed
44.
Zurück zum Zitat Kimber J, Dolan K, van Beek I, Hedrich D, Zurhold H. Drug consumption facilities: an update since 2000. Drug Alcohol Rev. 2003;22(2):227–33.CrossRefPubMed Kimber J, Dolan K, van Beek I, Hedrich D, Zurhold H. Drug consumption facilities: an update since 2000. Drug Alcohol Rev. 2003;22(2):227–33.CrossRefPubMed
45.
Zurück zum Zitat Lloyd C, Hunt N. Drug consumption rooms: an overdue extension to harm reduction policy in the UK? Int J Drug Policy. 2007;18(1):5–9. Lloyd C, Hunt N. Drug consumption rooms: an overdue extension to harm reduction policy in the UK? Int J Drug Policy. 2007;18(1):5–9.
46.
Zurück zum Zitat Small W, Fast D, Krusi A, Wood E, Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver Canada: a qualitative study. Subst Abuse Treat Prev Policy. 2009;4:8.CrossRefPubMedPubMedCentral Small W, Fast D, Krusi A, Wood E, Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver Canada: a qualitative study. Subst Abuse Treat Prev Policy. 2009;4:8.CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Rivera AV, DeCuir J, Crawford ND, Amesty S, Lewis CF. Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010-2012. Drug Alcohol Depend. 2014;144:259–64.CrossRefPubMedPubMedCentral Rivera AV, DeCuir J, Crawford ND, Amesty S, Lewis CF. Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010-2012. Drug Alcohol Depend. 2014;144:259–64.CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Meacham MC, Roesch SC, Strathdee SA, Lindsay S, Gonzalez-Zuniga P, Gaines TL. Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico. Drug Alcohol Rev . 2017. Meacham MC, Roesch SC, Strathdee SA, Lindsay S, Gonzalez-Zuniga P, Gaines TL. Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico. Drug Alcohol Rev . 2017.
49.
Zurück zum Zitat Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Jarlais DCD. Transitions to injecting drug use among noninjecting heroin users. Jaids J Acquir Immune Defic Syndr. 2006;41(4):493–503. Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Jarlais DCD. Transitions to injecting drug use among noninjecting heroin users. Jaids J Acquir Immune Defic Syndr. 2006;41(4):493–503.
50.
Zurück zum Zitat Buster MCA, Witteveen E, Prins M, van Ameijden EJC, Schippers G, Krol A. Transitions in drug use in a new generation of problem drug users in Amsterdam: a 6-year follow-up study. Eur Addict Res. 2009;15(4):179–87.CrossRefPubMed Buster MCA, Witteveen E, Prins M, van Ameijden EJC, Schippers G, Krol A. Transitions in drug use in a new generation of problem drug users in Amsterdam: a 6-year follow-up study. Eur Addict Res. 2009;15(4):179–87.CrossRefPubMed
51.
Zurück zum Zitat Strathdee SA, Fraga WD, Case P, et al. “Vivo para consumirla y la consumo para vivir” [“I live to inject and inject to live”]: high-risk injection behaviors in Tijuana, Mexico. J Urban Health . 2005;82(3 Suppl 4):iv58–73. Strathdee SA, Fraga WD, Case P, et al. “Vivo para consumirla y la consumo para vivir” [“I live to inject and inject to live”]: high-risk injection behaviors in Tijuana, Mexico. J Urban Health . 2005;82(3 Suppl 4):iv58–73.
52.
Zurück zum Zitat Pollini RA, Brouwer KC, Lozada RM, et al. Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities. Addiction. 2008;103(1):101–8.CrossRefPubMed Pollini RA, Brouwer KC, Lozada RM, et al. Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities. Addiction. 2008;103(1):101–8.CrossRefPubMed
53.
Zurück zum Zitat Miller CL, Firestone M, Ramos R, et al. Injecting drug users’ experiences of policing practices in two Mexican-U.S. border cities: public health perspectives. Int J Drug Policy. 2008;19(4):324–31. Miller CL, Firestone M, Ramos R, et al. Injecting drug users’ experiences of policing practices in two Mexican-U.S. border cities: public health perspectives. Int J Drug Policy. 2008;19(4):324–31.
54.
Zurück zum Zitat Werb D, Strathdee SA, Vera A, et al. Spatial patterns of arrests, police assault and addiction treatment center locations in Tijuana, Mexico. Addiction. n111(7):1246–56. Werb D, Strathdee SA, Vera A, et al. Spatial patterns of arrests, police assault and addiction treatment center locations in Tijuana, Mexico. Addiction. n111(7):1246–56.
Metadaten
Titel
Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico
verfasst von
Amen Ben Hamida
Claudia Rafful
Sonia Jain
Shelly Sun
Patricia Gonzalez-Zuniga
Gudelia Rangel
Steffanie A. Strathdee
Dan Werb
Publikationsdatum
16.08.2017
Verlag
Springer US
Erschienen in
Journal of Urban Health / Ausgabe 1/2018
Print ISSN: 1099-3460
Elektronische ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-017-0188-4

Weitere Artikel der Ausgabe 1/2018

Journal of Urban Health 1/2018 Zur Ausgabe